G118R and F121Y mutations identified in patients failing raltegravir treatment confer dolutegravir resistance. (2015)
Attributed to:
MRC Centre for Transplantation
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/jac/dku474
PubMed Identifier: 25414202
Publication URI: http://europepmc.org/abstract/MED/25414202
Type: Journal Article/Review
Volume: 70
Parent Publication: The Journal of antimicrobial chemotherapy
Issue: 3
ISSN: 0305-7453